IFNA1 and rheumatoid arthritis: We found that RA patients developing ANA were characterized by higher levels of IFNα (310 pg/ml vs. 47 pg/ml, P < 0.01), suggesting that infliximab influences pDC homeostasis and promotes the production of ANAs through the secretion of IFNα (Figure 4c).